GLP-1

3 statements across 1 episodes · 2 bullish · 0 bearish · 1 people on the record · first statement Jan 22, 2024 by David Rosenthal · said 1 times in 1 episodes since 2024 · across every show →

Mentions by year

brought up most by David Rosenthal (1)

tap a year for its mentions
0011112024episodesmentions
0112024episodes it came up in
000.50.5112024episodesmentions per episode
2024 1 mention in 1 episode

every mention, scene by scene, with the transcript →

Everything said about GLP-1, oldest first

Jan 22, 2024 positive
Assertion Supported
Eli Lilly's Byetta became the first GLP-1 drug on market
“Eli Lilly develops it into Bayetta, and Bayetta hits the market in 2005. It's FDA approved, and it works. It's not poisonous. It doesn't kill people. And it is the world's first GLP-I analog to come to market.”
David Rosenthal Jan 22, 2024 ▶ 1:54:11 Novo Nordisk (Ozempic) · Acquired
Jan 22, 2024
What-if
Novo Nordisk survived only because of its foundation ownership structure
“And, foreshadowing, there is a moment much later in history where, absent the control of this foundation, Novo Nordisk would have ceased to exist. It is only because of this structure that Novo Nordisk survived, and that we have GLP-I's and everything we have …”
David Rosenthal Jan 22, 2024 ▶ 34:48 Novo Nordisk (Ozempic) · Acquired
Jan 22, 2024 positive
Assertion Supported
Liraglutide extends GLP-1 half-life to 13 hours in humans
“Liraglutide ends up having a half-life in the human body of 13 hours compared to, you know, like, a half-life of two and a half minutes for straight up GLP-I.”
David Rosenthal Jan 22, 2024 ▶ 1:49:05 Novo Nordisk (Ozempic) · Acquired
Made with StarZero

Turn any episode into a week of clips.

This entire site, nearly 80 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.